Calbindin-D9k mRNA expression in the rat uterus following exposure to methoxychlor: A comparison of oral and subcutaneous exposure

Journal of Reproduction and Development

Volumn 53, Issue 2, 2007, Pages 179-188

  Shin, Jae Ho ^a   Moon, Hyun Ju ^a   Kang, Il Hyun ^a   Kim, Tae Sung ^a   Lee, Su Jung ^a   Oh, Ji Young ^a   Lee, Young Joo ^a   Hong, Eui Ju ^b   Jeung, Eui Bae ^b   Han, Soon Young ^a  

^a Korea Food and Drug Administration   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Calbindin D9k; Immature rat; Methoxychlor; Uterotrophic response

Indexed keywords

RATTUS;

CALBINDIN; MESSENGER RNA; METHOXYCHLOR;

ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS;

ADMINISTRATION, ORAL; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; FEMALE; GENE EXPRESSION REGULATION; INJECTIONS, SUBCUTANEOUS; METHOXYCHLOR; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UTERUS;

EID: 34248359527     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.18054     Document Type: Article

References (59)

1. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993; 101: 378-384.
2. Danzo BJ. The effects of a gonadotropin-releasing hormone antagonist on androgen-binding protein distribution and other parameters in the adult male rats. Endocrinology 1995; 136: 4004-4011.
3. Ankley GT, Johnson RD, Toth G, Fomar LC, Detenbeck NE, Bradbury SP. Development of a research strategy for assessing the ecological risk of endocrine disruptors. Rev Toxicol 1997; 1: 231-267.
4. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health 1999; 53: 289-296.
5. Yamada T, Kunimatsu T, Sako H, Yabushita S, Sukata T, Okuno Y, Matsuo M. Comparative evaluation of 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity. Toxicol Sci 2000; 53: 289-296.
6. Gray LE, Ostby J, Ferrell J, Rehnberg G, Linder R, Cooper R, Goldman J, Slott V, Laskey J. A dose-response analysis of methoxychor-induced alterations of reproductive development and function in rat. Fundam Appl Toxicol 1989; 12: 92-108.
7. Gray LE, Ostby J, Linder R, Goldman J, Rehnberg G, Cooper R. Carbendazim induced alterations of reproductive development and function in the rat and hamster. Fundam Appl Toxicol 1990; 15: 281-297.
8. O'Connor JC, Cook JC, Slone TW, Makovec GT, Frame SR, Cavis LG. An ongoing validation of a tier 1 screening battery for detecting endocrine-active compounds (EAC). Toxicol Sci 1998; 46: 45-60.
9. Gray LE, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T, Waller C, Foster P, Laskey J, Reel J, Giesy J, Laws S, McLachlan J, Breslin W, Cooper R, Giulio RD, Johnson R, Purdy R, Mihaich E, Safe S, Sonnenschein C, Welshons W, Miller R, McMaster S, Colborn T. Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod Toxicol 1997; 11: 719-750.
10. Gray LE, Ostby J, Cooper RL, Kelce WR. The estrogenic and antiandrogenic pesticide MC alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicol Ind Health 1999; 15: 37-47.
11. Gray LE, Wolf C, Lambright C, Lambright C, Mann P, Price M, Cooper RL, Ostby J. Administration of the potentially antiandrogenic pesticides (procymidone, linuron, chlozolinate, p,p′-DDE and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation in the male rat. Toxicol Ind Health 1999; 15: 94-118.
12. Kelce WR, Wilson EM. Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications. J MoI Med 1997; 75: 198-207.
13. Korach KS, Chae K, Gibson M, Curtis S. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness. Steroids 1991; 56: 263-270.
14. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 2000; 54: 154-167.
15. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspec 1995; 103 (Suppl 7): 83-87.
16. Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 1996; 104: 1296-1300.
17. Jorgensen M, Vendelbo B, Skakkebaek NE, Leffers H. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ Health Perspect 2000; 108: 403-412.
18. Miller S, Kennedy D, Thomson J, Han F, Smith R, Ing N, Piedrahita J, Busbee D. A rapid and sensitive reporter gene that uses green fluorescent protein expression to detect chemicals with estrogenic activity. Toxicol Sci 2000; 55: 69-77.
19. Balaguer P, Francois F, Comunale F, Fenet H, Boussioux AM, Pons M, Nicolas JC, Casellas C. Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci Total Environ 1999; 233: 47-56.
20. OECD. Detailed background review of the uterotrophic bioassay: Summary of the available literature in support of the project of the OECD task force on endocrine disrupters testing and assessment (EDTA) to standardize and validate the uterotrophic bioassay. OECD Environment, Health and Safety Publication Series on Testing and Assessment, No. 38. ENV/JM/MONO(2003)1. Paris: OECD. 2003.
21. Heppell SA, Denslow ND, Folmar LC, Sullivan CV. Universal assay of vitellogenin as a biomarker for environmental estrogens. Environ Health Perspect 1995; 103 (Suppl 7): 9-15.
22. Ren L, Marquardt MA, Lech JJ. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem Biol Interact 1997; 104: 55-64.
23. Kumar R, Wieben E, Beecher SJ. The molecular cloning of the complementary deoxyribonucleic acid for bovine vitamin D-dependent calcium-binding protein: structure of the full-length protein and evidence for homologies with other calcium-binding proteins of the troponin-C superfamily of proteins. Mol Endocrinol 1989; 3: 427-432.
24. Krisinger J, Dann JL, Currie WD, Jeung EB, Leung PC. Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus. Mol Cell Endocrinol 1992; 86: 119-123.
25. An BS, Kang SK, Shin JH, Jeung EB. Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol. Mol Cell Endocrinol 2002; 191: 177-186.
26. Hong EJ, Choi KC, Jeung EB. Maternal exposure to bisphenol A during late pregnancy resulted in an increase of Calbindin-D9k mRNA and protein in maternal and postnatal rat uteri. J Reprod Dev 2005; 51: 499-508.
27. Hong EJ, Ji YK, Choi KC, Manabe N, Jeung EB. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k. J Reprod Dev 2005; 51: 253-263.
28. Kim SS, Lee RD, Lim KJ, Kwack SJ, Rhee GS, Seok JH, Lee GS, An BS, Jeung EB, Park KL. Potential estrogenic and antiandrogenic effects of permethrin in rats. J Reprod Dev 2005; 51: 201-210.
29. Bulger WH, Muccitelli RM, Kupfer D. Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis(p-hydroxyphenyl)-1,1,1- trichloroethane with rat uterine estrogen receptor. J Toxicol Environ Health 1978; 4: 881-893.
30. Bulger WH, Muccitelli RM, Kupfer D. Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenase in methoxychlor activation. Biochem Pharmacol 1978; 27: 2417-2423.
31. Bulger WH, Feil VJ, Kupfer D. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants. Mol Pharmacol 1985; 27: 115-124.
32. Cummings AM, Gray LE. Antifertility effect of methoxychlor in female rats: dose- and time-dependent blockade of pregnancy. Toxicol Appl Pharmacol 1989; 97: 454-462.
33. Cummings AM, Laskey J. Effect of methoxychlor on ovarian steroidogenesis: role in early pregnancy loss. Reprod Toxicol 1993; 7: 17-23.
34. Cummings AM, Gray LE. Methoxychlor affects the decidual cell response of the uterus but not other progestational parameters in female rats. Toxicol Appl Pharmacol 1987; 90: 330-336.
35. Cummings AM, Perreault SD. Methoxychlor accelerates embryo transport through the rat reproductive tract. Toxicol Appl Pharmacol 1990; 102: 110-116.
36. Cummings AM, Metcalf JL. Mechanisms of the stimulation of rat uterine peroxidase activity by methoxychlor. Reprod Toxicol 1994; 8: 477-486.
37. Cummings AM, Metcalf JL. Methoxychlor regulates rat uterine estrogen-induced protein. Toxicol Appl Toxicol 1995; 130: 154-160.
38. Cummings AM, Laws SC. Assessment of estrogenicity by using the delayed implanting rat model and examples. Reprod Toxicol 2000; 14: 111-117.
39. Chapin RE, Harris MW, Davis BJ, Ward SM, Wilson RE, Mauney MA, Lockhart AC, Smialowicz RJ, Moser VC, Burka LT, Collins BJ. The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function. Fundam Appl Toxicol 1997; 40: 138-157.
40. Cummings AM. Methoxychlor as a model for environmental estrogens. Crit Rev Toxicol 1997; 27: 367-379.
41. Laws SC, Ferrell JM, Stoker TE, Cooper RL. Pubertal development in female Wistar rats following exposure to propazine and atrazine biotransformation by-products, diamino-S-chlorotriazine and hydroxyatrazine. Toxicol Sci 2003; 76: 190-200.
42. You L, Casanova M, Bartolucci EJ, Fryczynski MW, Dorman DC, Everitt JI, Gaido KW, Ross SM, Heck H. Combined effects of dietary phytoestrogen and synthetic endocrine-active compound on reproductive development in Sprague-Dawley rats: genistein and methoxychlor. Toxicol Sci 2002; 66: 91-104.
43. Gaido KW, Leonard LS, Maness SC, Hall JM, McDonnell DP, Saville B, Safe S. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxy phenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology 1999; 140: 5746-5753.
44. Hu Y, Kupfer D. Enantioselective metabolism of the endocrine disruptor pesticide methoxychlor by human cytochromes P450 (P450s): major differences in selective enantiomer formation by various P450 isoforms. Drug Metab Dispos 2002; 30: 1329-1336.
45. Hu Y, Kupfer D. Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metab Dispos 2002 ; 30: 1035-1042.
46. Frenich AG, Vidal JL, Frias MM, Olea-Serrano F, Olea N. Quantitative determination of endocrine-disrupting polychlorinated biphenyls and organochlorinated pesticides in human serum using gas chromatography with electron-capture detection and tandem mass spectrometry. J Mass Spectrom 2000; 35: 967-975.
47. Kupfer D, Bulger WH. Metabolic activation of pesticides with proestrogenic activity. Fed Proc 1987; 46: 1864-1869.
48. Kapoor IP, Metcalf RL, Nystrom RF, Sangha GK. Comparative metabolism of methoxychlor, methiochlor, and DDT in mouse, insects, and in a model ecosystem. J Agric Food Chem 1970; 18: 1145-1152.
49. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 2000; 54: 154-167.
50. Ousterhout J, Struck RF, Nelson JA. Estrogenic activities on methoxychlor metabolites. Biochem Pharmacol 1981; 30: 2869-2871.
51. Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol Pharmacol 2000; 58: 852-858.
52. Jensen EV, DeSombre ER. Estrogen-receptor interaction. Science 1973; 182: 126-134.
53. O'Malley BW, Means AR. Female steroid hormones and target cell nuclei. Science 1974; 183: 610-620.
54. Petit F, Le Goff P, Cravedi JP, Valotaire Y, Pakdel F. Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyte cultures. J Mol Endocrinol 1997; 19: 321-335.
55. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 1984; 12: 2861-2878.
56. Pavlovitch H, Clemens TL, Laouari D, O'Riordan JL, Balsan S. Lack of effect on ovariectomy on the metabolism of vitamin D and intestinal calcium-binding protein in female rats. J Endocrinol 1980; 86: 419-424.
57. Weikel JH. The metabolism of methoxychlor (1,1,1 trichloro 2,2-bis (p-methoxy phenyl) ethane). I. The role of the liver and biliary excretion in the rat. Arch Int Pharmacodyn Ther 1957; 110: 423-432.
58. Klaassen CD. Distribution, excretion and absorption of toxicant. In: Klassen CD (ed.), Toxicology: The Basic Sciences of Poisons. 3rd ed, New York: McMillan Publishing Company; 1986: 33-64.
59. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect 2003; 111: 1530-1549.